Cancer gene profile of metastatic breast cancer.

Authors

null

Funda Meric-Bernstam

University of Texas M. D. Anderson Cancer Center, Houston, TX

Funda Meric-Bernstam , Garrett Frampton , Jaime Ferrer-Lozano , Roman Yelensky , Gary A. Palmer , Maureen T. Cronin , Philip J Stephens , Katherine Stemke Hale , Juan Barrera , Octavio Burgues , Ana Lluch , Gordon B. Mills , Ana M. Gonzalez-Angulo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Triple-Negative Breast Cancer

Citation

J Clin Oncol 30, 2012 (suppl; abstr 1015)

DOI

10.1200/jco.2012.30.15_suppl.1015

Abstract #

1015

Poster Bd #

7

Abstract Disclosures

Similar Posters

Poster

2018 ASCO Annual Meeting

Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.

Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.

First Author: Razelle Kurzrock

Poster

2014 Gastrointestinal Cancers Symposium

Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).

Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).

First Author: Rachna T. Shroff